Biohaven’s first-in-class Molecular Degrader of Extracellular Proteins (MoDE™) technology targeting IgG removal, BHV-1300, was selected for an oral presentation at…
Browsing: Pharmaceuticals
PUNE, India, April 12, 2024 /PRNewswire/ — The report titled “STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab…
SILVER SPRING, Md., April 12, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary…
Presentations span Parkinson’s disease and ALS clinical and real-world evidence Oral platform sessions will highlight results from Phase 3 BouNDless…
STOCKHOLM, April 12, 2024 /PRNewswire/ — Diamyd Medical’s precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled…
MALVERN, Pa., April 11, 2024 /PRNewswire/ — Endo, Inc. (“Endo”), a newly formed entity, today announced that its wholly-owned subsidiary Endo…
The dynamics of the Usher syndrome market are anticipated to change rapidly in the coming years owing to the anticipated…
PONTE VEDRA, Fla., April 11, 2024 /PRNewswire/ — Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage…
CLEVELAND, April 11, 2024 /PRNewswire/ — More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud…